Follow Us
© 2026 Arizent. All rights reserved.
UnitedHealth Group Inc.’s OptumRx unit struck an agreement to ease customers’ access to drugs through Walgreens Boots Alliance Inc.’s drugstores, a move to help the business compete with rival pharmacy benefit managers.
Steve Miller, the pharmacy benefit manager’s chief medical officer, addresses the key cost drivers and what the PBM is doing to guard against increases.
Generic drugs are usually significantly cheaper for plan sponsors than brand-name drugs. Here’s a look at 10 drugs coming off patent in 2016. And although the FDA hasn’t yet approved generics for many of the following blockbuster drugs that are coming off patent this year, in most cases there are generics in the pipeline, according to Dickson Data Blog.
Steve Miller, the pharmacy benefit manager’s chief medical officer, addresses the key cost drivers and what the PBM is doing to guard against increases.
Excessive and expensive treatment is at the core of the healthcare cost crisis, says Brian Klepper.
Other countries and some innovative firms here consistently deliver equal or better quality care at dramatically lower cost, betraying the idea that conventional U.S. healthcare is superior or even appropriate.
Price comparison tools available to the public don’t make it easy enough for workers to make informed decisions.
They might, if they had better access to pricing information in the decision-making process, says Frenkel Benefits’ Craig Hasday.
Despite the continued escalation in specialty medication costs, many employers sponsoring self-funded health plans have not yet placed prescription drugs underneath the plans stop-loss insurance. Why is that?
Just four years after exiting the pharmacy benefit management business, Walgreens is getting back into it with the acquisition of pharmacy retail chain Rite-Aid.
Commentary: Pharma will feel the pain of regulation sooner than they expected, adviser Craig Hasday predicts.
Commentary: Many employers don't know what their PBMs are doing today to actually manage their specialty drug programs, says Lockton's Sarah Martin. It's up to advisers to shine a light on PBM practices.
The tire and wheel retailer implements a telehealth option for employees, providing online access to care for minor ailments.
Is the U.S. health care system overrated and overpriced?
Insurers are projecting significant jumps in pharmacy expenses this year, driven primarily by specialty drugs.
Satisfaction with supermarket and chain drug store pharmacies has increased slightly, while satisfaction with mail-order pharmacies has decreased.
With the cost of pharmaceuticals consuming an ever-increasing proportion of health benefit expenditures, many employers are responding by adding pricing tiers to their drug plan designs.
Commentary: Who would argue that spending $10,000 is worth the trade-off of cardiac surgery? Or $90,000 for drugs which might avoid a costly liver failure incident? A lot of employers, thats who.
Commentary: Disruption is the word of the day in the evolving health insurance industry.
CVS Health Corp. will pay $1.9 billion to buy Target Corp.s pharmacies and clinics, expanding its reach by adding stores bearing its name inside the U.S. retail chain.
